These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4679251)

  • 41. [Biological properties of 1,2-benzisothiazole compounds. Hypoglycemic activity of some benzisothiazolylacylamidoethylbenzensulfonylureas].
    Amoretti L; Agosti A; Catellani PL
    Boll Soc Ital Biol Sper; 1971 May; 47(10):299-302. PubMed ID: 4999859
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of diabetes mellitus with glibornurid].
    Vignati E; Liuzzi A; Chiodini PG
    Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract]   [Full Text] [Related]  

  • 43. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 45. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on long-term tolerance of glibornuride in the rat and in the dog].
    Schärer K; Heisler N; Sterner W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2188. PubMed ID: 4679248
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 49. When--and how--to use an oral agent.
    Shuman CR
    Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
    Giraudo JR
    Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
    [No Abstract]   [Full Text] [Related]  

  • 51. [Glibornuride (Glutril). A new peroral antidiabetic agent].
    Jervell J
    Tidsskr Nor Laegeforen; 1974 Mar; 94(9):589. PubMed ID: 4828084
    [No Abstract]   [Full Text] [Related]  

  • 52. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 54. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
    Herrlinger H; Dörfler H; Wolfram G; Zöllner N
    Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man.
    Ratheiser K; Korn A; Waldhäusl W; Komjati M; Vierhapper H; Badian M; Malerczyk V
    Arzneimittelforschung; 1993 Aug; 43(8):856-8. PubMed ID: 8216442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.
    CHRISTENSEN LK; HANSEN JM; KRISTENSEN M
    Lancet; 1963 Dec; 2(7321):1298-301. PubMed ID: 14071924
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [On the multiple-dose kinetics of glibornuride in man (author's transl)].
    Dubach UC; Korn A; Raaflaub J
    Arzneimittelforschung; 1975; 25(12):1967-9. PubMed ID: 130138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.